openPR Logo
Press release

Cancer Genetics, Inc Awarded 3 Qualifying Therapeutic Discovery Project Grants

11-12-2010 02:14 PM CET | Health & Medicine

Press release from: Cancer Genetics, Inc

Rutherford, NJ – www.cancergenetics.com – Cancer Genetics, Inc (CGI), an emerging leader in personalized treatment for cancer, has been awarded 3 grants to further commercialize molecular diagnostics for oncology. CGI has announced that these grants were issued from the Qualifying Therapeutic Discovery Project program under section 48D of the Internal Revenue Code. This program was created under the Affordable Care Act and is aimed to fund projects and initiatives that demonstrate the ability to advance new therapies, reduce long-term healthcare costs, or take steps to curing cancer within the next 30 years. CGI’s founder, Dr. R.S.K. Chaganti says, “The success with this award is a clear validation of CGI's novel approaches and innovative technologies towards taking molecular diagnostics of cancer to the next level.” The three funded projects cover personalized treatment and diagnosis in the areas of: mature b-cell neoplasms, HPV-associated cancers, and renal cancer. CGI is expected to commercialize these products over the next year, with an initial launch in late November of 2010 of the lymphoma microarray, MatBA™.

The Qualifying Therapeutic Discovery Project program was allotted $1 billion for credits and grants to fund projects designed to improve health and save lives. The IRS, in conjunction with the Department of Health and Human Services, reviewed applications for projects that showed significant potential to produce new and cost-saving therapies, support jobs and increase U.S. competitiveness. Projects aimed in the determination of molecular factors through the use of molecular diagnostics to guide therapeutic decisions were highly regarded in the selection process. CGI aims to develop diagnostic assays for prognosis of cancer that help to guide effective treatments and reduce healthcare costs. The funding is geared towards making testing and diagnostic services more affordable, allow for further clinical trials, and educate medical personnel on the information and usage of CGI products.

Qualified Therapeutic Discovery Projects at CGI:

MatBA™
A microarray-based comparative genomic hybridization (CGH) assay developed to detect chromosomal gains and losses frequently observed in mature B-cell neoplasm. In MatBA™-CLL application, DNA gains and losses in chronic lymphocytic leukemia (CLL) are detected and physicians can utilize the results to assist in the diagnosis and prognosis of CLL.

FHACT™
Used as a patented-pending diagnostic tool, FHACT™ is a DNA-FISH based assay that can identify chromosomal changes in HPV-associated cancers. FHACT™, when used as a reflex test for abnormal cytology specimens, will provide a new level of triage to patients with an HPV-positive status. By identifying the type of abnormalities and the stage of cervical cancer progression, FHACT™ can be used to determine the most suitable treatment for the patient that is the least invasive and most cost-effective

FReCaD™
This FISH-based renal cancer detection (FReCaD) assay is designed to differentially diagnose the four main subtypes of renal cortical neoplasm. By detecting inherent genomic rearrangement to renal cancer subtypes, FReCaD assay allows a more accurate diagnosis and subsequently the determination of personalized clinical management leading to a higher remission rate and the prevention of disease progression.

Contact: Jessica Kissen
JKissen@cancergenetics.com
(201) 528-9196

About Cancer Genetics, Inc (CGI)
Based in of Rutherford, NJ, CGI was founded by Dr. R.S.K. Chaganti in 1999 and has become an emerging leader in personalized cancer treatment. CGI’s synergistic business model provides cancer-focused diagnostic testing services to leading oncologists, pathologists, hospitals, and academics centers as well as the development of next-generation diagnostic products that leverage CGI’s unique IP in molecular genetics and oncology. Products developed by CGI are revolutionizing the management and treatment of certain cancers as well as reducing healthcare costs. The company can be found on the Internet at www.cancergenetics.com or reached at (201) 528-9200.

Cancer Genetics, Inc
Jessica Kissen
Marketing and Communications Coordinator
Meadowlands Office Complex
201 Route 17 North, 2nd Floor
Rutherford, NJ
07070

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Genetics, Inc Awarded 3 Qualifying Therapeutic Discovery Project Grants here

News-ID: 151505 • Views:

More Releases from Cancer Genetics, Inc

Cancer Genetics, Inc Awarded 3 Qualifying Therapeutic Discovery Project Grants
--Cancer Genetics, Inc (CGI) granted over $735 thousand for research and development of unique diagnostic research for cancer-- Rutherford, NJ – www.cancergenetics.com – Cancer Genetics, Inc (CGI), an emerging leader in personalized treatment for cancer, has been awarded 3 grants to further commercialize molecular diagnostics for oncology. CGI has announced that these grants were issued from the Qualifying Therapeutic Discovery Project program under section 48D of the Internal Revenue Code. This

More Releases for CGI

Health Insurance Exchange Market May See Big Move | CGI, Deloitte, IBM, Infosys
Latest Study on Industrial Growth of Global Health Insurance Exchange (HIX) Market 2022-2028. A detailed study accumulated to offer Latest insights about acute features of the Health Insurance Exchange (HIX) market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of
Cognitively Guided Instruction (CGI) Market Research on Present State and Future …
The Cognitively Guided Instruction (CGI) market report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each region and country involved in the study. Furthermore, It studies the market essential sectors such as top participants, expansion strategies, business models, and other industry features to improve the current strategy of key players. Facts and data are presented in reports using diagrams, graphs, pie charts, and
Software Consulting Market 2018 | CGI Group Inc., Deloitte Touche Tohmatsu Limit …
Global Software Consulting Market: Snapshot The demand within the global software consulting market is rising on account of advancements in the field of information and communication technologies. Several companies are in need of software consulting, and this is a key consideration for the market vendors. The success of software consulting firms depends on their ability to provide customized advice and solutions to end users. The needs and software requirements of businesses
Software Consulting Market -Geographical Analysis 2028 | CGI Group Inc., Cogniza …
Global Software Consulting Market: Overview The demand within the global market for software consulting has been expanding on account of the quest of businesses to maximise their productivity through the use of key application software. Commercial businesses in the contemporary scenario have become largely dependent on software tools and program to manoeuvre their business and effectuate processes. Owing to these factors, the demand within the global market for software consulting has
Software Consulting Market - Forecasts future opportunities 2028 | CGI Group Inc …
Global Software Consulting Market: Overview The demand within the global market for software consulting has been expanding on account of the quest of businesses to maximise their productivity through the use of key application software. Commercial businesses in the contemporary scenario have become largely dependent on software tools and program to manoeuvre their business and effectuate processes. Owing to these factors, the demand within the global market for software consulting has
Precision Gearboxes Market 2017 - CGI, GAM, Apex Dynamics, Girard, ElectroCraft
Apex Research, recently published a detailed market research study focused on the "Precision Gearboxes Market" across the global, regional and country level. The report provides 360° analysis of "Precision Gearboxes Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Precision Gearboxes industry, and estimates the future trend of Precision Gearboxes market on